Allergan heads to federal court to defend Restasis against early generic rivals

29th August 2017 Uncategorised 0

In defense of a top seller, Allergan is squaring off against a cadre of generics companies in Texas federal court, accusing copycat drugmakers of violating its patent protections on blockbuster eye medication Restasis.

More: Allergan heads to federal court to defend Restasis against early generic rivals
Source: fierce